- About us
- About Vaccines
- Media centre
- Become a member
- VE Day 2013
Vaccination at the Heart of Public Health. Vaccines Europe calls on EU policy-makers to develop a comprehensive vaccination strategy through five core policy asks.
How long for a vaccine to reach European Population? 6,4 years is the median time lag between marketing authorisation and effective population access
Vaccines Europe acts as the cohesive voice of the Europe-based vaccine industry sector and is a trusted partner for public authorities. Find out more about our association and contribution to Europe.
With 47% growth in R&D investment over the past eight years and over 70% of current R&D projects based on new antigens and new combinations, Vaccines Europe members highly contribute to innovation.
As the EU-wide recognised vaccine industry stakeholder, Vaccines Europe represents major innovative research-based vaccine companies operating in Europe and is currently expanding to SMEs.
Find out more about our services, the opportunites we offer and how to become a member.
Vaccine companies are actively working on the development of effective prophylactic vaccines capable of preventing Ebola Virus Disease (EVD) and halting the ongoing outbreak in West Africa. This is the first outbreak of this kind and it is rapidly spreading across countries in the region, making it unprecedented in size and geographical distribution. So far, the World Health Organisation (WHO) reports 7178 cases, including 3338 deaths. Read more…
(5 June – Lyon, FRANCE): Vaccines Europe today launched a campaign calling for a coherent vaccination strategy in Europe, with a clearer and more comprehensive agenda to “prevent the preventable”.
The campaign’s roadmap “PREVENTION FIRST: Vaccination at the heart of public health” proposes some actions to be addressed by EU authorities to develop a vaccination strategy for Europe. This aims to support EU Members States in achieving their immunisation policy objectives. Spending in primary prevention currently represents less than 3% of Member States’ overall healthcare budgets, and there is plenty of scope for further action to strengthen diseases prevention programmes. Read more…
It is with deep regret that Vaccines Europe announces that the Brazilian epidemiologist Dr. Ciro de Quadros, who was a central figure in the eradication of polio from Latin America and the Caribbean, passed away a week ago. De Quadros, who was the Executive Vice President of the Sabin Vaccine Institute and Director of Sabin’s Vaccine Advocacy and Education program, was a renowned public health expert and advocate, in particular, in the area of vaccines and preventable diseases.
He has recently been honored as a Public Health Hero of the Americas by the Pan American Health Organization/World Health Organization (PAHO/WHO), which is the PAHO’s highest distinction. With this prize PAHO believed that no single person has done more to extend the benefits of immunization to people throughout the Americas.
Vaccines Europe members and staff offer their sincere condolences to Dr de Quadros’ family.